Torbjorn Wisloff
Overview
Explore the profile of Torbjorn Wisloff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
754
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Vo C, Samuelsen P, Sommerseth H, Wisloff T, Wilsgaard T, Eggen A
BMC Public Health
. 2023 May;
23(1):994.
PMID: 37248482
Background: Differences in the sociodemographic characteristics of participants and non-participants in population-based studies may introduce bias and reduce the generalizability of research findings. This study aimed to compare the sociodemographic...
22.
Johansen M, Eriksrud O, Thorkildsen J, Norum O, Wisloff T, Taksdal I, et al.
Surg Oncol
. 2023 Apr;
48:101944.
PMID: 37062091
Objective: To assess muscle strength characteristics in patients with resection and megaprosthetic reconstruction of the knee for bone sarcoma compared to age- and sex-matched controls. Methods: This was a cross-sectional,...
23.
Vervaart M, Aas E, Claxton K, Strong M, Welton N, Wisloff T, et al.
Med Decis Making
. 2023 Mar;
43(5):595-609.
PMID: 36971425
Background: Expected value of sample information (EVSI) quantifies the expected value to a decision maker of reducing uncertainty by collecting additional data. EVSI calculations require simulating plausible data sets, typically...
24.
Nilsen T, Saeter M, Sarvari S, Reinertsen K, Johansen S, Edvardsen E, et al.
JMIR Res Protoc
. 2023 Mar;
12:e45244.
PMID: 36920460
Background: Anthracycline-based chemotherapy has been mainstay of adjuvant breast cancer therapy for decades. Although effective, anthracyclines place long-term breast cancer survivors at risk of late effects, such as reduced cardiorespiratory...
25.
Johannessen T, Halvorsen S, Atar D, Munkhaugen J, Nore A, Wisloff T, et al.
BMC Health Serv Res
. 2022 Oct;
22(1):1274.
PMID: 36271364
Aims: Hospital admissions of patients with chest pain considered as low risk for acute coronary syndrome contribute to increased costs and crowding in the emergency departments. This study aims to...
26.
Vo C, Samuelsen P, Sommerseth H, Wisloff T, Wilsgaard T, Eggen A
Scand J Public Health
. 2022 May;
51(7):1061-1068.
PMID: 35593433
Background: Self-reported data on educational level have been collected for decades in the Tromsø Study, but their validity has yet to be established. Aim: To investigate the completeness and correctness...
27.
Nilsen T, Johansen S, Thorsen L, Fairman C, Wisloff T, Raastad T
Int J Environ Res Public Health
. 2022 Apr;
19(7).
PMID: 35409505
Background: Loss of muscle mass and muscle function is a common side effect from androgen deprivation therapy (ADT) for prostate cancer (PCa). Here, we explored effects of heavy-load resistance training...
28.
Li X, Bilcke J, Vazquez Fernandez L, Bont L, Willem L, Wisloff T, et al.
J Infect Dis
. 2022 Mar;
226(Suppl 1):S95-S101.
PMID: 35292816
Background: Every winter, respiratory syncytial virus (RSV) disease results in thousands of cases in Norwegian children under 5 years of age. We aim to assess the RSV-related economic burden and...
29.
Sahba M, Krog A, Pettersen E, Wisloff T, Sundhagen J, Kazmi S
Vasc Health Risk Manag
. 2022 Feb;
18:61-71.
PMID: 35221689
Background: QoL assessment within surgical treatment is seldom investigated and sparsely reported in the medical literature. This study aimed to compare QoL in a randomized fashion in the patients treated...
30.
Parr C, Nystad W, Karlstad O, Oymar K, Langhammer A, Nafstad P, et al.
Allergy
. 2022 Jan;
77(5):1614-1616.
PMID: 35048378
No abstract available.